Literature DB >> 8043975

AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDS.

B S Kamps1, H R Brodt, S Staszewski, L Bergmann, E B Helm.   

Abstract

The clinical history of 1538 HIV positive patients was analyzed on the basis of the new CDC classification system of HIV disease and AIDS. This classification system combines three CD4 cell categories (1, 2, and 3) with three clinical categories (A, B, and C) into nine subgroups A1-C3. We examined the overall survival for all subgroups and the AIDS-free survival for subgroups A1-B3. AIDS-free survival for patients in subgroups A1, A2, and B1 was considerably longer than survival in patients from subgroups A3, B2, and B3 (P < 0.0001). According to these findings, the new CDC classification system could be simplified into three stages, stage I and II comprising the above mentioned six subgroups, and stage III comprising clinical AIDS defining categories C1, C2, and C3. These three stages correspond to different periods in the management of HIV positive patients, i.e., period of observation, period of prophylaxis, and period of treatment.

Entities:  

Mesh:

Year:  1994        PMID: 8043975     DOI: 10.1007/bf00180041

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  10 in total

1.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.

Authors:  G W Rutherford; A R Lifson; N A Hessol; W W Darrow; P M O'Malley; S P Buchbinder; J L Barnhart; T W Bodecker; L Cannon; L S Doll
Journal:  BMJ       Date:  1990-11-24

2.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-05-23       Impact factor: 17.586

3.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS.

Authors:  W Lang; H Perkins; R E Anderson; R Royce; N Jewell; W Winkelstein
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

4.  The Walter Reed staging classification for HTLV-III/LAV infection.

Authors:  R R Redfield; D C Wright; E C Tramont
Journal:  N Engl J Med       Date:  1986-01-09       Impact factor: 91.245

5.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

Authors:  H Masur; F P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; W Travis; A F Suffredini; L Deyton; J A Kovacs; J Falloon
Journal:  Ann Intern Med       Date:  1989-08-01       Impact factor: 25.391

6.  Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group.

Authors:  A Muñoz; M C Wang; S Bass; J M Taylor; L A Kingsley; J S Chmiel; B F Polk
Journal:  Am J Epidemiol       Date:  1989-09       Impact factor: 4.897

7.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

Authors:  J J Goedert; R J Biggar; M Melbye; D L Mann; S Wilson; M H Gail; R J Grossman; R A DiGioia; W C Sanchez; S H Weiss
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

8.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

9.  Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.

Authors:  E Fernández-Cruz; M Desco; M Garcia Montes; N Longo; B Gonzalez; J M Zabay
Journal:  AIDS       Date:  1990-10       Impact factor: 4.177

10.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

  10 in total
  4 in total

1.  Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: effects on chemokine receptor utilization.

Authors:  A L Hammond; J Lewis; J May; J Albert; P Balfe; J A McKeating
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study.

Authors:  I Reiter-Owona; R Bialek; J K Rockstroh; H M Seitz
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

3.  Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer.

Authors:  Felipe Ortiz-Gutiérrez; Lilia Sánchez-Minutti; José F Martínez-Herrera; Indiana D Torres-Escobar; Elias B Pezzat-Said; Luis Márquez-Domínguez; Amado I Grandes-Blanco
Journal:  Pol J Microbiol       Date:  2021-12-23

4.  Factors Influencing Immune Restoration in People Living with HIV/AIDS.

Authors:  Bogusz Jan Aksak-Wąs; Anna Urbańska; Kaja Scheibe; Karol Serwin; Magdalena Leszczyszyn-Pynka; Milena Rafalska-Kosior; Joanna Gołąb; Daniel Chober; Miłosz Parczewski
Journal:  J Clin Med       Date:  2022-03-28       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.